This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (29)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Neurogenetics  • Genetic Counseling/ Testing/ Therapy  • Genetic Disorders  • Alert me on articles by topic

Inge A. Meijer, BSc; Collette K. Hand, PhD; P. Cossette, MD, MSc; Denise A. Figlewicz, PhD; Guy A. Rouleau, MD, PhD

Arch Neurol. 2002;59:281-286.

Background  Hereditary spastic paraplegia (HSP) is a neurodegenerative disease characterized by progressive spasticity and weakness of the lower limbs. The most common form of HSP is caused by mutations in the SPG4 gene, which codes for spastin, an adenosine triphosphatase with various cellular activities (AAA) protein family member.

Objective  To investigate a large collection of predominantly North American patients with HSP for mutations in the spastin encoding gene, SPG4.

Methods  DNA from 76 unrelated affected individuals was studied for mutations by single-stranded conformational polymorphism analysis and direct sequencing. Each new variant identified was then analyzed in 80 control subjects to determine whether the variant is a common polymorphism or a rare mutation. All DNA samples were amplified by polymerase chain reaction, followed by electrophoresis and autoradiography.

Results  We identified 8 novel mutations and 5 previously reported mutations in 15 affected individuals. The novel mutations are 4 missense, 1 nonsense, 1 frameshift, and 2 splice mutations. Two polymorphisms (one in an affected individual) were also identified.

Conclusions  Our collection of families with HSP is different on a genetic level from those previously described. The percentage of our families with a SPG4 mutation is 10% lower than the 40% estimate of families with autosomal dominant HSP noted to be linked to this locus, and splice mutations are not predominant in our collection. Interestingly, we also identified 2 recurring mutations in specific populations (R562Q and G559D), which may facilitate the development of future spastin diagnostic testing in these populations.

From the Centre for Research in Neuroscience, McGill University, The Montreal General Hospital Research Institute, Montreal, Quebec (Ms Meijer, and Drs Hand, Cossette, and Rouleau); and the Department of Neurology, University of Rochester Medical Center, Rochester, NY (Dr Figlewicz).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quantitative and Functional Analyses of Spastin in the Nervous System: Implications for Hereditary Spastic Paraplegia
Solowska et al.
J. Neurosci. 2008;28:2147-2157.
ABSTRACT | FULL TEXT  

Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia
Depienne et al.
J. Med. Genet. 2007;44:281-284.
ABSTRACT | FULL TEXT  

A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition
Tarrade et al.
Hum Mol Genet 2006;15:3544-3558.
ABSTRACT | FULL TEXT  

High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia
Beetz et al.
Neurology 2006;67:1926-1930.
ABSTRACT | FULL TEXT  

Clinical features of hereditary spastic paraplegia due to spastin mutation.
McDermott et al.
Neurology 2006;67:45-51.
ABSTRACT | FULL TEXT  

Eight Novel Mutations in SPG4 in a Large Sample of Patients With Hereditary Spastic Paraplegia.
Crippa et al.
Arch Neurol 2006;63:750-755.
ABSTRACT | FULL TEXT  

Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases
Depienne et al.
J. Med. Genet. 2006;43:259-265.
ABSTRACT | FULL TEXT  

Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners
Sanderson et al.
Hum Mol Genet 2006;15:307-318.
ABSTRACT | FULL TEXT  

Early-onset ALS with long-term survival associated with spastin gene mutation
Meyer et al.
Neurology 2005;65:141-143.
ABSTRACT | FULL TEXT  

A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts
Orlacchio et al.
Neurology 2004;62:1875-1878.
ABSTRACT | FULL TEXT  

Three Novel Mutations of the Spastin Gene in Chinese Patients With Hereditary Spastic Paraplegia
Tang et al.
Arch Neurol 2004;61:49-55.
ABSTRACT | FULL TEXT  

Subtle Cognitive Impairment but No Dementia in Patients With Spastin Mutations
Tallaksen et al.
Arch Neurol 2003;60:1113-1118.
ABSTRACT | FULL TEXT  

Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias
Reid
J. Med. Genet. 2003;40:81-86.
ABSTRACT | FULL TEXT  

Mutations of SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized in the nucleus
Charvin et al.
Hum Mol Genet 2003;12:71-78.
ABSTRACT | FULL TEXT